Cantoni F, Barbe L, Roy A, Wicher G, Simonsson S, Forsberg-Nilsson K
APL Bioeng. 2024; 8(4):046113.
PMID: 39634677
PMC: 11617029.
DOI: 10.1063/5.0227135.
Xiang X, Nan Y
Zhongguo Fei Ai Za Zhi. 2024; 27(9):697-703.
PMID: 39492585
PMC: 11534582.
DOI: 10.3779/j.issn.1009-3419.2024.106.24.
Neel E, Chiritoiu-Butnaru M, Fargues W, Denus M, Colladant M, Filaquier A
J Cell Biol. 2024; 223(9).
PMID: 39133205
PMC: 11318669.
DOI: 10.1083/jcb.202404152.
Bhat M, Nambiar A, Edakkandiyil L, Abraham I, Sen R, Negi M
Mol Biol Cell. 2024; 35(8):mr6.
PMID: 38888935
PMC: 11321044.
DOI: 10.1091/mbc.E23-09-0344.
Deng T, Lu X, Jia X, Du J, Wang L, Cao B
Front Endocrinol (Lausanne). 2024; 15:1428433.
PMID: 38883596
PMC: 11176415.
DOI: 10.3389/fendo.2024.1428433.
Tumor associated macrophages as key contributors and targets in current and future therapies for melanoma.
Habib S, Osborn G, Willsmore Z, Chew M, Jakubow S, Fitzpatrick A
Expert Rev Clin Immunol. 2024; 20(8):895-911.
PMID: 38533720
PMC: 11286214.
DOI: 10.1080/1744666X.2024.2326626.
Network-based analysis of heterogeneous patient-matched brain and extracranial melanoma metastasis pairs reveals three homogeneous subgroups.
Grutzmann K, Kraft T, Meinhardt M, Meier F, Westphal D, Seifert M
Comput Struct Biotechnol J. 2024; 23:1036-1050.
PMID: 38464935
PMC: 10920107.
DOI: 10.1016/j.csbj.2024.02.013.
Cell signaling and epigenetic regulation of nicotine-induced carcinogenesis.
Sun Q, Jin C
Environ Pollut. 2024; 345:123426.
PMID: 38295934
PMC: 10939829.
DOI: 10.1016/j.envpol.2024.123426.
XTX101, a tumor-activated, Fc-enhanced anti-CTLA-4 monoclonal antibody, demonstrates tumor-growth inhibition and tumor-selective pharmacodynamics in mouse models of cancer.
Jenkins K, Park M, Pederzoli-Ribeil M, Eskiocak U, Johnson P, Guzman W
J Immunother Cancer. 2024; 11(12).
PMID: 38164757
PMC: 10729150.
DOI: 10.1136/jitc-2023-007785.
The Journey of Cancer Cells to the Brain: Challenges and Opportunities.
Lazarczyk M, Mickael M, Skiba D, Kurzejamska E, Lawinski M, Horbanczuk J
Int J Mol Sci. 2023; 24(4).
PMID: 36835266
PMC: 9967224.
DOI: 10.3390/ijms24043854.
Mechanisms of ADC Toxicity and Strategies to Increase ADC Tolerability.
Nguyen T, Bordeau B, Balthasar J
Cancers (Basel). 2023; 15(3).
PMID: 36765668
PMC: 9913659.
DOI: 10.3390/cancers15030713.
The role and regulation of Maf proteins in cancer.
Deng Y, Lu L, Zhang H, Fu Y, Liu T, Chen Y
Biomark Res. 2023; 11(1):17.
PMID: 36750911
PMC: 9903618.
DOI: 10.1186/s40364-023-00457-w.
The roles of proteases in prostate cancer.
Koistinen H, Kovanen R, Hollenberg M, Dufour A, Radisky E, Stenman U
IUBMB Life. 2023; 75(6):493-513.
PMID: 36598826
PMC: 10159896.
DOI: 10.1002/iub.2700.
Divergent regulation of basement membrane trafficking by human macrophages and cancer cells.
Bahr J, Li X, Feinberg T, Jiang L, Weiss S
Nat Commun. 2022; 13(1):6409.
PMID: 36302921
PMC: 9613642.
DOI: 10.1038/s41467-022-34087-x.
Kallikrein-Related Peptidase 6 (KLK6) as a Contributor toward an Aggressive Cancer Cell Phenotype: A Potential Role in Colon Cancer Peritoneal Metastasis.
Bouzid H, Soualmia F, Oikonomopoulou K, Soosaipillai A, Walker F, Louati K
Biomolecules. 2022; 12(7).
PMID: 35883559
PMC: 9312869.
DOI: 10.3390/biom12071003.
Selective targeting of metastatic ovarian cancer using an engineered anthrax prodrug activated by membrane-anchored serine proteases.
Duru N, Pawar N, Martin E, Buzza M, Conway G, Lapidus R
Proc Natl Acad Sci U S A. 2022; 119(28):e2201423119.
PMID: 35867758
PMC: 9282395.
DOI: 10.1073/pnas.2201423119.
Matriptase-2/NR4A3 axis switches TGF-β action toward suppression of prostate cancer cell invasion, tumor growth, and metastasis.
Lin H, Ko C, Lo T, Wu S, Lan S, Huang C
Oncogene. 2022; 41(20):2833-2845.
PMID: 35418692
DOI: 10.1038/s41388-022-02303-z.
The physiological and pathophysiological roles of the autophagy lysosomal system in the conventional aqueous humor outflow pathway: More than cellular clean up.
Shim M, Liton P
Prog Retin Eye Res. 2022; 90:101064.
PMID: 35370083
PMC: 9464695.
DOI: 10.1016/j.preteyeres.2022.101064.
Role of Serine Proteases at the Tumor-Stroma Interface.
Tagirasa R, Yoo E
Front Immunol. 2022; 13:832418.
PMID: 35222418
PMC: 8873516.
DOI: 10.3389/fimmu.2022.832418.
Cleaved CDCP1 marks the spot: a neoepitope for RAS-driven cancers.
Donahue K, Pasca di Magliano M
J Clin Invest. 2022; 132(4).
PMID: 35166242
PMC: 8843638.
DOI: 10.1172/JCI157168.